Financhill
Buy
63

EKSO Quote, Financials, Valuation and Earnings

Last price:
$8.18
Seasonality move :
1.7%
Day range:
$8.50 - $10.10
52-week range:
$2.73 - $12.90
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
8.20x
P/B ratio:
2.38x
Volume:
563.7K
Avg. volume:
4.3M
1-year change:
-29.16%
Market cap:
$23M
Revenue:
$17.9M
EPS (TTM):
-$3.98
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $8.9M $11.2M $12.9M $18.3M $17.9M
Revenue Growth (YoY) -36.18% 26.62% 14.81% 41.57% -1.94%
 
Cost of Revenues $3.6M $4.2M $6.3M $8.6M $7.7M
Gross Profit $5.3M $7.1M $6.6M $9.7M $10.2M
Gross Profit Margin 59.55% 62.72% 51.42% 53.06% 57.13%
 
R&D Expenses $2.5M $2.7M $3.6M $5M $3.9M
Selling, General & Admin $15.5M $17.8M $18.1M $19.2M $16.1M
Other Inc / (Exp) -$2.8M $4.2M $632K $216K -$601K
Operating Expenses $18.1M $20.9M $22.2M $24.8M $20.7M
Operating Income -$12.9M -$13.8M -$15.6M -$15.1M -$10.5M
 
Net Interest Expenses $139K $113K $156K $302K $269K
EBT. Incl. Unusual Items -$15.8M -$9.8M -$15.1M -$15.2M -$11.3M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$15.8M -$9.8M -$15.1M -$15.2M -$11.3M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$15.8M -$9.8M -$15.1M -$15.2M -$11.3M
 
Basic EPS (Cont. Ops) -$2.21 -$0.80 -$1.16 -$1.10 -$8.43
Diluted EPS (Cont. Ops) -$2.21 -$0.88 -$1.16 -$1.10 -$8.43
Weighted Average Basic Share $7.2M $12.2M $13M $13.9M $20.2M
Weighted Average Diluted Share $7.2M $12.3M $13M $13.9M $20.2M
 
EBITDA -$12.2M -$13.3M -$14.7M -$13.4M -$8.9M
EBIT -$12.9M -$13.8M -$15.6M -$15.1M -$10.5M
 
Revenue (Reported) $8.9M $11.2M $12.9M $18.3M $17.9M
Operating Income (Reported) -$12.9M -$13.8M -$15.6M -$15.1M -$10.5M
Operating Income (Adjusted) -$12.9M -$13.8M -$15.6M -$15.1M -$10.5M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $3M $3.3M $4.6M $4.1M $4.2M
Revenue Growth (YoY) 5.25% 9.18% 38.39% -10.38% 2.37%
 
Cost of Revenues $1.2M $1.6M $2.2M $1.9M $1.7M
Gross Profit $1.8M $1.7M $2.5M $2.2M $2.5M
Gross Profit Margin 59.27% 50.65% 53.31% 53.5% 60.3%
 
R&D Expenses $618K $936K $1.2M $777K $550K
Selling, General & Admin $4M $4.4M $4.2M $4.1M $3.4M
Other Inc / (Exp) $855K -$616K -$370K $646K --
Operating Expenses $4.6M $5.3M $5.4M $4.8M $4M
Operating Income -$2.8M -$3.7M -$2.9M -$2.6M -$1.4M
 
Net Interest Expenses $24K $34K $64K $79K $18K
EBT. Incl. Unusual Items -$2M -$4.3M -$3.4M -$2.1M -$1.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$2M -$4.3M -$3.4M -$2.1M -$1.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$2M -$4.3M -$3.4M -$2.1M -$1.4M
 
Basic EPS (Cont. Ops) -$0.15 -$0.33 -$0.24 -$0.10 -$0.54
Diluted EPS (Cont. Ops) -$0.17 -$0.33 -$0.24 -$0.10 -$0.54
Weighted Average Basic Share $12.7M $13.1M $14.1M $20.3M $2.6M
Weighted Average Diluted Share $12.7M $13.1M $14.1M $20.3M $2.6M
 
EBITDA -$2.6M -$3.5M -$2.6M -$2.2M -$1M
EBIT -$2.8M -$3.7M -$2.9M -$2.6M -$1.4M
 
Revenue (Reported) $3M $3.3M $4.6M $4.1M $4.2M
Operating Income (Reported) -$2.8M -$3.7M -$2.9M -$2.6M -$1.4M
Operating Income (Adjusted) -$2.8M -$3.7M -$2.9M -$2.6M -$1.4M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $9.4M $13.4M $17M $17.7M $14.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $3.6M $6.5M $8.6M $8.5M $6.9M
Gross Profit $5.8M $7M $8.4M $9.2M $7.9M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $2.6M $3.7M $4.5M $4.3M $3.2M
Selling, General & Admin $15.3M $19M $20M $16.5M $15.7M
Other Inc / (Exp) $1.5M $1M $1.2M $824K --
Operating Expenses $18.1M $22.6M $24.5M $20.8M $18.9M
Operating Income -$12.3M -$15.7M -$16.1M -$11.7M -$11M
 
Net Interest Expenses $103K $126K $318K $276K $214K
EBT. Incl. Unusual Items -$10.9M -$14.8M -$15.2M -$11.1M -$10.4M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$10.9M -$14.8M -$15.2M -$11.1M -$10.4M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$10.9M -$14.8M -$15.2M -$11.1M -$10.4M
 
Basic EPS (Cont. Ops) -$1.07 -$1.15 -$1.12 -$0.65 -$3.98
Diluted EPS (Cont. Ops) -$1.10 -$1.18 -$1.12 -$0.65 -$3.98
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA -$11.7M -$14.9M -$14.8M -$9.8M -$9.5M
EBIT -$12.3M -$15.7M -$16.1M -$11.7M -$11M
 
Revenue (Reported) $9.4M $13.4M $17M $17.7M $14.7M
Operating Income (Reported) -$12.3M -$15.7M -$16.1M -$11.7M -$11M
Operating Income (Adjusted) -$12.3M -$15.7M -$16.1M -$11.7M -$11M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $7.2M $9.4M $13.4M $12.8M $9.7M
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $2.8M $4.8M $6.7M $6M $4.5M
Gross Profit $4.4M $4.5M $6.7M $6.8M $5.2M
Gross Profit Margin -- -- -- -- --
 
R&D Expenses $1.9M $2.9M $3.7M $3M $2.4M
Selling, General & Admin $11.7M $12.8M $14.7M $12M $11.6M
Other Inc / (Exp) $2.5M -$692K -$84K $523K $2M
Operating Expenses $13.7M $15.7M $18.4M $15M $14M
Operating Income -$9.3M -$11.1M -$11.7M -$8.2M -$8.8M
 
Net Interest Expenses $77K $90K $252K $210K $155K
EBT. Incl. Unusual Items -$6.9M -$11.9M -$12M -$7.9M -$7M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -$6.9M -$11.9M -$12M -$7.9M -$7M
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -$6.9M -$11.9M -$12M -$7.9M -$7M
 
Basic EPS (Cont. Ops) -$0.60 -$0.92 -$0.88 -$0.43 -$1.90
Diluted EPS (Cont. Ops) -$0.62 -$0.92 -$0.88 -$0.43 -$1.90
Weighted Average Basic Share $36.1M $38.7M $41M $56M $30.2M
Weighted Average Diluted Share $36.2M $38.7M $41M $56M $30.2M
 
EBITDA -$8.8M -$10.5M -$10.6M -$7M -$7.7M
EBIT -$9.3M -$11.1M -$11.7M -$8.2M -$8.8M
 
Revenue (Reported) $7.2M $9.4M $13.4M $12.8M $9.7M
Operating Income (Reported) -$9.3M -$11.1M -$11.7M -$8.2M -$8.8M
Operating Income (Adjusted) -$9.3M -$11.1M -$11.7M -$8.2M -$8.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $12.9M $40.4M $20.5M $8.6M $6.5M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3.4M $4.7M $4.6M $5.6M $7.2M
Inventory $2M $2.2M $5.2M $5.1M $4.6M
Prepaid Expenses -- -- -- -- --
Other Current Assets $356K $485K $700K $875K $541K
Total Current Assets $18.4M $47.8M $31M $20.2M $18.8M
 
Property Plant And Equipment $1.9M $1.2M $4M $3M $2.4M
Long-Term Investments -- -- -- -- --
Goodwill -- -- $431K $431K $431K
Other Intangibles -- -- $5.2M $4.9M $4.6M
Other Long-Term Assets $320K $164K $231K $392K $433K
Total Assets $20.6M $49.2M $40.9M $28.9M $26.7M
 
Accounts Payable $1.5M $3.1M $3.2M $1.8M $1.6M
Accrued Expenses $1.4M $2.3M $2.3M $2.7M $2.4M
Current Portion Of Long-Term Debt -- -- $2.3M $1.3M $1.3M
Current Portion Of Capital Lease Obligations $548K $229K $341K $363K $427K
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $5M $6.9M $9.2M $8.1M $7.5M
 
Long-Term Debt $3.3M $2M $4.9M $5.6M $4.3M
Capital Leases -- -- -- -- --
Total Liabilities $16.2M $11.9M $15.5M $16.3M $13.9M
 
Common Stock $8K $13K $13K $15K $22K
Other Common Equity Adj -$847K -$17K $563K $156K $957K
Common Equity $4.4M $37.2M $25.4M $12.6M $190.6M
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $4.4M $37.2M $25.4M $12.6M $12.7M
 
Total Liabilities and Equity $20.6M $49.2M $40.9M $28.9M $26.7M
Cash and Short Terms $12.9M $40.4M $20.5M $8.6M $6.5M
Total Debt $3.3M $2M $7.2M $6.8M $5.6M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $43.4M $29.2M $9.9M $8.3M $2.7M
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $3.1M $3.4M $5.9M $7M $6M
Inventory $1.8M $3.5M $5.5M $5M $5M
Prepaid Expenses -- -- -- -- --
Other Current Assets $788K $668K $1.1M $779K --
Total Current Assets $49.1M $36.8M $22.4M $21.1M $14.8M
 
Property Plant And Equipment $1.5M $2.3M $3.1M $2.5M $1.9M
Long-Term Investments -- -- -- -- --
Goodwill -- -- $431K $431K --
Other Intangibles -- -- $5M $4.7M --
Other Long-Term Assets $125K $224K $279K $531K --
Total Assets $50.7M $39.3M $31.2M $29.2M $21.7M
 
Accounts Payable $1.3M $2.4M $2.5M $1.8M $1.7M
Accrued Expenses $1.7M $2.2M $2.1M $2M --
Current Portion Of Long-Term Debt -- -- $1.3M $1.3M --
Current Portion Of Capital Lease Obligations $372K $244K $351K $434K --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $4.7M $7.9M $7.8M $7.5M $8.9M
 
Long-Term Debt $2M $1.2M $5.9M $4.7M $1.3M
Capital Leases -- -- -- -- --
Total Liabilities $11.7M $10.7M $15.9M $14.3M $12M
 
Common Stock $13K $13K $14K $22K $36K
Other Common Equity Adj -$246K $1.5M $733K $12K --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total -- -- -- -- --
Total Equity $39.1M $28.6M $15.3M $14.9M $9.7M
 
Total Liabilities and Equity $50.7M $39.3M $31.2M $29.2M $21.7M
Cash and Short Terms $43.4M $29.2M $9.9M $8.3M $2.7M
Total Debt $2M $3.2M $7.1M $5.9M $2.6M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$15.8M -$9.8M -$15.1M -$15.2M -$11.3M
Depreciation & Amoritzation $620K $561K $887K $1.7M $1.6M
Stock-Based Compensation $2.4M $2.3M $2.5M $1.9M $1.4M
Change in Accounts Receivable $1.8M -$1.6M -$67K -$1.2M -$2M
Change in Inventories $379K -$752K -$1.4M $232K $257K
Cash From Operations -$8.8M -$11.2M -$14.7M -$12.1M -$9.8M
 
Capital Expenditures -- $59K $194K $157K $37K
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -$59K -$5.2M -$157K -$37K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $3.1M -- -- -- --
Long-Term Debt Repaid -$2.8M -- -- -$313K -$1.3M
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $10.7M $38.7M -- $348K $7.8M
 
Beginning Cash (CF) $12.9M $40.4M $20.5M $8.6M $6.5M
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $2M $27.5M -$19.9M -$11.9M -$2.1M
Ending Cash (CF) $14.9M $68M $626K -$3.3M $4.3M
 
Levered Free Cash Flow -$8.8M -$11.2M -$14.9M -$12.2M -$9.9M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$2M -$4.3M -$3.4M -$2.1M -$1.4M
Depreciation & Amoritzation $158K $170K $342K $407K $367K
Stock-Based Compensation $663K $537K $441K $406K $234K
Change in Accounts Receivable -$430K -$184K -$830K -$398K -$1.5M
Change in Inventories -$35K -$256K $121K -$71K $494K
Cash From Operations -$2.5M -$2.6M -$3.4M -$2.3M -$2.1M
 
Capital Expenditures $60K $141K $17K $8K $12K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$60K -$141K -$17K -$8K -$12K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$313K --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- $4.7M -$437K
 
Beginning Cash (CF) $43.4M $29.2M $9.9M $8.3M $2.7M
Foreign Exchange Rate Adjustment $36K -$1K -- $1K -$10K
Additions / Reductions -$2.5M -$2.7M -$3.4M $2.4M -$2.5M
Ending Cash (CF) $41M $26.4M $6.6M $10.7M $192K
 
Levered Free Cash Flow -$2.5M -$2.7M -$3.4M -$2.3M -$2.1M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$10.9M -$14.8M -$15.2M -$11.1M -$10.4M
Depreciation & Amoritzation $586K $762K $1.3M $1.9M $1.5M
Stock-Based Compensation $2.3M $2.4M $2.3M $1.5M $998K
Change in Accounts Receivable $1M -$570K -$2.5M -$1.3M $1M
Change in Inventories -$160K -$2.1M -$85K $314K -$50K
Cash From Operations -$9.8M -$14.1M -$14.1M -$10M -$8.9M
 
Capital Expenditures $60K $140K $167K $59K $83K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$60K -$140K -$5.1M -$59K -$83K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$1.3M --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $38.7M -- -- $8.4M $3.4M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $28.9M -$14.3M -$19.2M -$1.6M -$5.6M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -$9.9M -$14.3M -$14.3M -$10.1M -$9M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders -$6.9M -$11.9M -$12M -$7.9M -$7M
Depreciation & Amoritzation $431K $632K $1M $1.2M $1.1M
Stock-Based Compensation $1.5M $1.6M $1.4M $1.1M $691K
Change in Accounts Receivable -$10K $1M -$1.3M -$1.4M $1.5M
Change in Inventories -$171K -$1.5M -$162K -$80K -$387K
Cash From Operations -$8.1M -$11M -$10.5M -$8.4M -$7.5M
 
Capital Expenditures $60K $141K $114K $16K $62K
Cash Acquisitions -- -- -- -- --
Cash From Investing -$60K -$141K -$114K -$16K -$62K
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -$938K -$625K
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing $38.7M -- -- $8.1M $3.7M
 
Beginning Cash (CF) $138.9M $97.3M $39.5M $23M $16M
Foreign Exchange Rate Adjustment $6K -$41K -$4K $0 $53K
Additions / Reductions $30.6M -$11.2M -$10.6M -$346K -$3.8M
Ending Cash (CF) $169.5M $86M $28.9M $22.6M $12.3M
 
Levered Free Cash Flow -$8.1M -$11.2M -$10.6M -$8.4M -$7.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Stan Druckenmiller Sell Broadcom Stock?
Why Did Stan Druckenmiller Sell Broadcom Stock?

In Q3, legendary macro investor Stan Druckenmiller sold his entire…

Why Is CoreWeave Stock Down So Much?
Why Is CoreWeave Stock Down So Much?

AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…

Why Did Stan Druckenmiller Buy MercadoLibre Stock?
Why Did Stan Druckenmiller Buy MercadoLibre Stock?

In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…

Stock Ideas

Buy
59
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
70
RGC alert for Jan 8

Regencell Bioscience Holdings Ltd. [RGC] is down 21.5% over the past day.

Buy
64
RVMD alert for Jan 8

Revolution Medicines, Inc. [RVMD] is up 4.61% over the past day.

Sell
38
CRNX alert for Jan 8

Crinetics Pharmaceuticals, Inc. [CRNX] is down 0.23% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock